Tuberculosis infection following immune checkpoint inhibitor treatment for advanced cancer: a case report and literature review.

Lin, Chen; Xu, Guixiang; Gao, Shuyan; Feng, Tao; Li, Shuang

Lin, Chen; Xu, Guixiang; Gao, Shuyan; Feng, Tao; Li, Shuang.

Afiliação

Lin C; Department of Respiratory and Critical Care Medicine, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Xu G; Department of Respiratory and Critical Care Medicine, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Gao S; Department of Respiratory and Critical Care Medicine, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Feng T; Department of Respiratory and Critical Care Medicine, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Li S; Department of Respiratory and Critical Care Medicine, Shengli Oilfield Central Hospital, Dongying, Shandong, China.

Front Immunol ; 14: 1162190, 2023.

Article em En | MEDLINE | ID: mdl-37304292

Assuntos

Carcinoma de Células Escamosas; Tuberculose Latente; Tuberculose; Feminino; Masculino; Humanos; Idoso; Inibidores de Checkpoint Imunológico/efeitos adversos; Tuberculose/diagnóstico; Tuberculose/tratamento farmacológico; Imunoterapia/efeitos adversos

Palavras-chave

drug-related adverse reactions; immune checkpoint inhibitors; interferon-Î³ release assay; tuberculosis; tuberculosis screening

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Carcinoma de Células Escamosas / Tuberculose Latente Tipo de estudo: Diagnostic_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google